Mars mission bone-loss model shows risk, but relies on outdated data and untested assumptions

Potential bone density loss and osteoporosis risk for astronauts on Mars missions could compromise skeletal health and fracture resistance during landing and surface operations.
A crewed Mars vehicle will need enough mechanical loading to persuade the skeleton it still lives in a world with weight.
The closing observation on what mission designers must engineer into any long-duration deep-space vehicle.
Mark

Why does a model based on 69 astronauts who flew for six months matter for a three-year Mars mission?

Mimi

Because we have no three-year human spaceflight data. The model is a stress test—it asks what happens if the bone loss we observe in short flights continues unchecked across a much longer mission. It's not a prediction; it's a warning about what we need to prevent.

Mark

But the percentages in the headlines sound like they're describing what will actually happen.

Mimi

That's the trap. The model outputs are real, but they describe modeled demographic cases under worst-case assumptions with no countermeasures. They're not measured incidence rates. A real astronaut would start with their own bone scans, health history, and response to training—not just their demographic category.

Mark

So modern exercise equipment changes everything?

Mimi

It changes a lot. ARED can keep astronauts on six-month ISS missions close to their preflight bone density. But ARED is massive and requires the full infrastructure of the space station. A Mars vehicle needs something smaller that works in a confined space for three years. That's never been tested.

Mark

What about the Martian surface? Doesn't that partial gravity help?

Mimi

We don't know. Mars has 38 percent of Earth's gravity—enough to make falls and heavy equipment relevant, but no human has ever lived there for months. The model doesn't account for it separately because there's no data. The surface stay might slow bone loss, stabilize it, or be too weak to matter. That's still an open question.

Mark

If the model is so limited, why publish it?

Mimi

Because it's honest about its limits and it quantifies the problem. It tells mission designers exactly what they need to solve. The alternative—ignoring the question until astronauts are already on their way—is worse.

Mark

What's the actual risk to a Mars crew?

Mimi

Unknown. The model suggests it could be significant without countermeasures. But we have better exercise protocols now, better nutrition, better monitoring. The real risk depends on what we actually send with them and how well it works over three years. That's what needs testing.

  • A peer-reviewed model projects that astronauts on 1,000-to-1,200-day Mars missions could lose up to 37 percent of femoral-neck bone density—enough to push every modeled case into osteopenic territory and roughly a third into osteoporosis.
  • The alarm rests on an enormous extrapolation: data from 69 astronauts on flights no longer than 228 days was stretched across mission profiles nearly five times as long, with almost the entire Mars-range curve built from projection rather than observation.
  • The model was built before modern resistance exercise systems reached the space station, omitting the countermeasures that have since allowed many six-month crews to return with bone density near preflight levels.
  • Mars missions add layers the model could not resolve—partial Martian gravity at 38 percent of Earth's, compact hardware that cannot replicate the ISS exercise suite, deep-space radiation, and no human data from anything approaching three years away from Earth.
  • Mission planners must now engineer a solution to a problem that has never been directly observed: keeping a skeleton structurally sound through an outbound cruise, a surface stay, and a return voyage, with no validated countermeasure package for that duration.

Long before any human sets foot on Mars, a mathematical model has already mapped the slow erosion of bone that the journey might demand. Researchers extrapolating from shorter spaceflight missions projected that astronauts on multi-year expeditions could lose a third or more of critical hip-bone density—a forecast that is less a clinical verdict than a quantified challenge issued to mission designers. The warning is real, but it is built from curves extended far beyond their observed foundations, and the countermeasures it ignored have since changed the picture on the International Space Station. What remains unresolved is whether human bone, persuaded by gravity for a lifetime, can be persuaded otherwise by machines alone across three years of deep space.

A 2020 study in PLOS One projected that astronauts on three-year Mars missions could lose between 32 and 37 percent of their femoral-neck bone density, with all modeled cases falling into the osteopenic range and roughly one-third crossing into osteoporosis. The numbers are striking—and they require careful reading.

No one has flown to Mars. The forecast came from fitting a curve to bone-density measurements taken from 69 astronauts on missions lasting 132 to 228 days, then extending that curve across profiles of 1,000 to 1,200 days. Nearly the entire Mars-range portion of that curve is extrapolation. The researchers used a nonlinear model to avoid the physical absurdity of a straight line eventually predicting negative bone density, anchoring the projected plateau at a 69 percent loss drawn from terrestrial analogues—prolonged bed rest and spinal-cord injury—rather than from astronauts observed until their loss actually leveled off.

The study examined two mission architectures. A shorter opposition-class profile of 400 to 600 days projected a 15 to 22 percent density reduction. The longer conjunction-class profile, lasting roughly 2.7 to 3.3 years, produced the 32 to 37 percent figure. T-scores—the clinical measure of how far density sits from a young-adult reference—were calculated using population averages rather than the individual scans of actual Mars candidates, which shapes what the headline percentages really mean: they describe modeled demographic cases crossing diagnostic thresholds, not the measured probability that a given astronaut will fracture a hip on landing.

The model's most consequential omission is exercise. The astronaut data predated the Advanced Resistive Exercise Device, introduced to the space station in 2009, which loads the body through movements resembling squats and deadlifts. Combined with adequate nutrition, ARED changed the bone story on the ISS—later crews returned with density close to preflight values, and NASA's current performance standards call for keeping the femoral neck at or above 90 percent of pre-mission levels on six-month flights. Most crewmembers now meet that target.

But a six-month station mission is not a Mars expedition. ARED is large and depends on ISS infrastructure; a compact substitute must reproduce sufficient loading with far fewer resources. The model also treated total mission duration as a single variable, giving Mars's partial gravity—38 percent of Earth's—no separate protective role, because no human data exists from months spent at that gravity level. Whether the surface stay would slow bone loss, establish a new equilibrium, or prove too weak to matter remains unknown.

The projection is neither destiny nor a dismissed curiosity. It is a quantified description of what engineers and physiologists must prevent. A crewed Mars vehicle will carry propulsion, shielding, and life support. It will also need to carry, in some form, enough mechanical loading to convince the human skeleton that weight still exists—across a journey for which no validated countermeasure has yet been tested.

A mathematical model published in 2020 predicted that astronauts on three-year Mars missions could lose between 32 and 37 percent of their femoral-neck bone density, with every modeled case dropping into the osteopenic range and roughly one-third crossing into outright osteoporosis. The percentages sound alarming. They are also, in a crucial sense, not what they appear to be.

No human being has traveled to Mars. No astronaut has returned from Mars with weakened bones. The striking forecast came not from clinical observation of an interplanetary crew but from a mathematical extrapolation—researchers took bone-density measurements from 69 astronauts who had flown between 132 and 228 days, fitted a curve to that short-duration data, and extended it across mission profiles lasting 1,000 to 1,200 days. The gap between what was measured and what was projected is enormous. Almost the entire curve that runs through the Mars windows is extrapolation, not observation.

The distinction matters for how we read the warning. In microgravity, the mechanical demands on bone largely vanish. The balance between bone formation and resorption shifts. The femoral neck—the narrow region where the thighbone connects to the hip—normally bears load from standing and movement. Without that load, density declines. The 2020 study, published in PLOS One by researchers from NASA Ames and Stanford, used a nonlinear model rather than a simple linear projection. A straight line would eventually predict bone density below zero, a physical impossibility. The nonlinear approach bent toward a plateau, set at a 69 percent loss from preflight density, drawn from terrestrial evidence of prolonged bed rest and spinal-cord injury.

The researchers tested two broad mission architectures. An opposition-class profile lasted 400 to 600 days—shorter but requiring more demanding velocity changes and substantially more fuel. A conjunction-class profile lasted 1,000 to 1,200 days, roughly 2.7 to 3.3 years, using more favorable Earth-Mars geometry and generally considered easier with conventional propulsion. For the shorter option, the model projected a 15.6 to 22 percent reduction in femoral-neck density. For the longer option, the loss reached 32.4 to 36.8 percent. The authors then converted those estimates into T-scores—a measure of how far a person's bone density sits above or below a young-adult reference mean—using average preflight densities from national health surveys rather than the individual scans of actual Mars candidates.

This methodological detail reshapes what the percentages mean. The "62 percent" and "100 percent" results in headlines describe the share of modeled demographic cases crossing diagnostic thresholds under the study's assumptions. They are not measured incidence rates and should not be read as the probability that a randomly selected future astronaut will develop osteoporosis. Osteopenia and osteoporosis are not two separate diagnoses a person holds at once; osteoporosis is the lower-density category. When the abstract predicted that 100 percent of conjunction-class cases would develop osteopenia and 33 percent would be at risk of osteoporosis, the clearest reading is that all reached at least the osteopenic range, while roughly one-third crossed the more severe threshold. Even that does not translate directly into a fracture forecast. Bone mineral density contributes to bone strength, but geometry, microarchitecture, accumulated microscopic damage, and the load applied at a particular moment also matter.

The most significant limitation of the 2020 model is what it did not include. The astronaut data came from flights before the Advanced Resistive Exercise Device, or ARED, was introduced to the space station in 2009. The study did not model exercise, diet, medication or other countermeasures. It also omitted possible damage from prolonged deep-space radiation. ARED can load the body through movements resembling squats, deadlifts, and heel raises. Combined with adequate energy intake and vitamin D, it changed the bone response seen in later crews. A NASA technical summary reported that astronauts with access to ARED could return from station missions with bone mineral density close to preflight values, although bone turnover remained altered. NASA's current human-performance requirements call for countermeasures to keep the femoral neck at or above 90 percent of pre-mission density. The agency says most crewmembers on six-month missions return within those deficit limits. That is better evidence than the older input data, but it does not erase the Mars problem. A six-month station mission is not a three-year expedition. The large ARED installation benefits from the space, structure, maintenance and logistics of the ISS. NASA notes that it cannot simply fit inside an exploration spacecraft, so smaller devices must reproduce enough loading with fewer resources.

No countermeasure package has been validated in humans for 1,000 to 1,200 days away from Earth. A round-trip Mars mission is not usually three uninterrupted years of microgravity either. It contains an outbound cruise, time on the Martian surface where gravity is 38 percent of Earth's, and a return cruise. The 2020 model used total mission duration as its time variable and did not give Mars's partial gravity a separate protective term. That is understandable because there are no human data from months at 0.38 g, but it means the forecast cannot tell us whether the surface stay would slow loss, produce a new equilibrium, or be too weak to restore meaningful loading. The assumed 69 percent plateau came from Earth analogues rather than astronauts observed until their loss leveled off. Spinal-cord injury and bed rest reproduce skeletal unloading in useful ways, but they are not Mars missions. Spaceflight changes fluids, muscles, radiation exposure, daily movement and many other conditions at the same time.

The headline's percentages are real outputs of a peer-reviewed model. They are not direct observations, guarantees, or current NASA forecasts for a named mission architecture. Since the 2020 publication, current exercise and nutritional practice has supplied reasons for less pessimism. It has not supplied a three-year human dataset. Partial gravity, compact exercise hardware, deep-space radiation, autonomous medical care, and the durability of bone quality remain open parts of the problem. That makes the projection neither destiny nor a curiosity. It is a quantified description of what mission designers must prevent. A crewed Mars vehicle will carry engines, shielding and life support. It will also need to carry enough mechanical loading, in some form, to persuade the human skeleton that it still lives in a world with weight.

The model is a stress test for mission planning: if femoral-neck bone mineral density followed the assumed trajectory and if no effective countermeasures altered it, a long Mars expedition could push every modelled case below the normal range.
— 2020 PLOS One study authors (NASA Ames and Stanford)
No countermeasure package has been validated in humans for 1,000 to 1,200 days away from Earth.
— Source analysis
Contattaci Domande frequenti